Related Experiment Video
Updated: Jun 17, 2026
19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistance
Jing Zhang1, Tingjun Hou, Wei Wang
1Department of Statistics, Harvard University, Science Center, 1 Oxford St, Cambridge, MA 02138, USA.
Summary
Understanding HIV drug resistance is key to new treatments. This study models mutations to reveal how HIV viruses resist drugs, aiding in developing better HIV therapies.
Area of Science:
- Virology
- Computational Biology
- Drug Discovery
Background:
- HIV drug resistance arises from viral mutations.
- Understanding mutation combinations is crucial for effective HIV treatment.
- Existing methods may not fully capture complex resistance mechanisms.
Purpose of the Study:
- To develop a systematic approach for understanding HIV drug resistance.
- To identify and analyze mutation combinations conferring resistance to HIV drugs.
- To elucidate the molecular interactions underlying viral resistance.
Main Methods:
- Probabilistic modeling of mutations in HIV-1 protease and reverse transcriptase (RT).
- Statistical procedure to detect resistance-associated mutation combinations.
- Molecular dynamics simulations and free energy calculations to study molecular basis.
Main Results:
- Identified specific mutation combinations associated with resistance to Indinavir, Zidovudine, and Nevirapine.
- Discovered unique interaction features between drug-induced viral mutations.
- Revealed the structural basis of these interactions.
Conclusions:
- The systematic approach effectively detects and analyzes HIV drug resistance mutations.
- Understanding mutation interactions aids in optimizing current HIV therapies and designing new ones.
- Provides insights into the molecular mechanisms of HIV drug resistance.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...